Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014-2018.
Criminal legal system
Incarceration
Methadone
Opioids
Reentry
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
07 Jul 2023
07 Jul 2023
Historique:
received:
07
03
2023
accepted:
25
05
2023
medline:
10
7
2023
pubmed:
8
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
We investigated the interaction between arrests for technical violations vs. receiving new charges with receiving community-based methadone treatment on time-to reincarceration (TTR) in a cohort of men with opioid use disorder (OUD) released from custody from two Connecticut jails from 2014 to 2018. Hazard ratios (HR) were estimated for time to reincarceration for technical violations/infractions, misdemeanors only, felonies only, and both misdemeanors and felonies after adjusting for age, race/ethnicity, and receiving methadone treatment during incarceration or in the community following release. Moderation analyses tested the hypotheses that the benefits of receiving methadone in jail or the community on TTR were significantly different for people with only technical violations and infractions compared to misdemeanor and felony charges. In the sample of 788 men who were reincarcerated, 29.4% received technical violations with no new charges (n = 232) with the remainder of the sample receiving new charges consisting of 26.9% new misdemeanor charges, 6.5% felony charges, and 37.2% both felony and misdemeanor charges. Compared to men who received new misdemeanor charges, TTR was significantly shorter among those who received technical violations and infractions with no new charges amounting to a 50% increase in TTR (334.5 days, SD = 321.3 vs. 228.1 days, SD = 308.0, p < 0.001; aHR = 1.5, 95% CI = 1.3, 1.8, p < 0.001). TTR of men who resumed methadone and were charged with a new crime was 50% longer than those who resumed methadone and received technical violations/infractions with no new charges. (230.2 days, SD = 340.2 vs. 402.3 days, SD = 231.3; aHR = 1.5, 95%CI = 1.0, 2.2, p = 0.038). Reducing technical violations may enhance the benefits of providing community-based methadone following release from incarceration on extending the time between incarcerations during the vulnerable time post-incarceration and reduce the burden on correctional systems.
Sections du résumé
BACKGROUND
BACKGROUND
We investigated the interaction between arrests for technical violations vs. receiving new charges with receiving community-based methadone treatment on time-to reincarceration (TTR) in a cohort of men with opioid use disorder (OUD) released from custody from two Connecticut jails from 2014 to 2018.
METHODS
METHODS
Hazard ratios (HR) were estimated for time to reincarceration for technical violations/infractions, misdemeanors only, felonies only, and both misdemeanors and felonies after adjusting for age, race/ethnicity, and receiving methadone treatment during incarceration or in the community following release. Moderation analyses tested the hypotheses that the benefits of receiving methadone in jail or the community on TTR were significantly different for people with only technical violations and infractions compared to misdemeanor and felony charges.
RESULTS
RESULTS
In the sample of 788 men who were reincarcerated, 29.4% received technical violations with no new charges (n = 232) with the remainder of the sample receiving new charges consisting of 26.9% new misdemeanor charges, 6.5% felony charges, and 37.2% both felony and misdemeanor charges. Compared to men who received new misdemeanor charges, TTR was significantly shorter among those who received technical violations and infractions with no new charges amounting to a 50% increase in TTR (334.5 days, SD = 321.3 vs. 228.1 days, SD = 308.0, p < 0.001; aHR = 1.5, 95% CI = 1.3, 1.8, p < 0.001). TTR of men who resumed methadone and were charged with a new crime was 50% longer than those who resumed methadone and received technical violations/infractions with no new charges. (230.2 days, SD = 340.2 vs. 402.3 days, SD = 231.3; aHR = 1.5, 95%CI = 1.0, 2.2, p = 0.038).
CONCLUSIONS
CONCLUSIONS
Reducing technical violations may enhance the benefits of providing community-based methadone following release from incarceration on extending the time between incarcerations during the vulnerable time post-incarceration and reduce the burden on correctional systems.
Identifiants
pubmed: 37420271
doi: 10.1186/s13011-023-00541-2
pii: 10.1186/s13011-023-00541-2
pmc: PMC10329353
doi:
Substances chimiques
Analgesics, Opioid
0
Methadone
UC6VBE7V1Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
43Subventions
Organisme : NIDA NIH HHS
ID : T32019426
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Drug Alcohol Depend. 2017 Sep 1;178:512-518
pubmed: 28719885
Drug Alcohol Depend. 2021 Oct 1;227:108937
pubmed: 34371235
Subst Abus. 2012;33(1):30-9
pubmed: 22263711
Addiction. 2012 Jun;107(6):1099-108
pubmed: 22175445
Am J Public Health. 2018 Sep;108(9):1207-1213
pubmed: 30024795
Psychiatr Serv. 2018 Nov 1;69(11):1124-1126
pubmed: 30185122
BMJ Open. 2014 Apr 02;4(4):e004666
pubmed: 24694626
Multivariate Behav Res. 1980 Jul 1;15(3):281-97
pubmed: 26794183
Addiction. 2023 Mar;118(3):459-467
pubmed: 36305669
Psychiatr Serv. 2006 Apr;57(4):544-9
pubmed: 16603751
J Subst Abuse Treat. 2016 Nov;70:1-6
pubmed: 27692182
Int J Drug Policy. 2022 Feb;100:103534
pubmed: 34896932
Addiction. 2021 Jun;116(6):1460-1471
pubmed: 33047844
J Am Acad Psychiatry Law. 2020 Jun;48(2):209-215
pubmed: 32051198
Addiction. 2009 Jul;104(7):1233-40
pubmed: 19426291
Health Justice. 2013 Dec 19;1(6):
pubmed: 25309847
PLoS Med. 2019 Dec 31;16(12):e1003002
pubmed: 31891578
J Subst Abuse Treat. 2019 Apr;99:32-43
pubmed: 30797392
Int J Drug Policy. 2021 May;91:102841
pubmed: 32712165
JAMA Psychiatry. 2018 Apr 1;75(4):405-407
pubmed: 29450443
PLoS One. 2020 Jan 21;15(1):e0227968
pubmed: 31961908
J Dual Diagn. 2013 Jan 1;9(1):11-22
pubmed: 23543790
Eur Addict Res. 2014;20(4):192-9
pubmed: 24513717
J Subst Abuse Treat. 2009 Oct;37(3):277-85
pubmed: 19339140
Drug Alcohol Depend. 2018 Dec 1;193:42-47
pubmed: 30340144
Biometrics. 2013 Jun;69(2):427-35
pubmed: 23441822
Addiction. 2015 Jun;110(6):1008-14
pubmed: 25703440
Drug Alcohol Depend. 2022 Feb 1;231:109254
pubmed: 35063323
Addiction. 2012 Feb;107(2):372-80
pubmed: 21851442